Skip to main content
Steffen Schmitz-Valckenberg
( out of 520 reviews )

Steffen Schmitz-Valckenberg, MD

Languages spoken: English, German

Clinical Locations

Primary Location

Farmington Health Center

165 N. University Ave.
Farmington , UT 84025

Midvalley Health Center

Moran Eye Center
243 East 6100 South
Murray , UT 84107

John A. Moran Eye Center

65 N Mario Capecchi
Salt Lake City , UT 84132

Steffen Schmitz-Valckenberg, MD, specializes in clinical and surgical treatment of macular and retinal diseases, including age-related macular degeneration (AMD), and is an expert in high-resolution retinal imaging.

Dr. Schmitz-Valckenberg co-founded and directed the Grading of Digital Fundus Examination Reading Center at the University of Bonn, Germany, where he was the Department of Ophthalmology’s assistant medical director. As an expert in high-resolution retinal and fundus autofluorescence imaging, he has used various imaging techniques to map the stages of decline in AMD. Researchers worldwide use this mapping to measure outcomes during interventional clinical trials.

At Moran, Dr. Schmitz-Valckenberg is directing an ophthalmic image reading center that will play a key role in the Sharon Eccles Steele Center for Translational Medicine's drive to take a new therapy for a prevalent form of AMD into clinical trials.

Dr. Schmitz-Valckenberg holds a Jon M. Huntsman Presidential Chair at the University of Utah and is a prolific researcher with more than 165 publications and 120 peer-reviewed articles. His honors include being named by The Ophthalmologist to its Power List 2017: Top 50 Rising Stars.

Get to know Dr. Schmitz-Valckenberg by watching his profile video.

Board Certification

Medical Association of North Rhine-Ophthalmology
European Board of Ophthalmology

Patient Rating

4.7 /5
( out of 520 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

MORAN EYE CENTER

He was a good doctor.

FARMINGTON HEALTH CENTER

An exceptional physician who I trust implicitly with my care.

FARMINGTON HEALTH CENTER

The best!

FARMINGTON HEALTH CENTER

Very Knowledgeable.

FARMINGTON HEALTH CENTER

Very caring and thoughtful

MORAN EYE CENTER

Easy to talk to. Hes very patient.

MORAN EYE CENTER

Dr. Schmitz-Valckenberg is a wonderful, competent, caring physician.

FARMINGTON HEALTH CENTER

The Dr expained very thing to me

MORAN EYE CENTER

Excellent care provider with great experience and caring professionalism.

Steffen Schmitz-Valckenberg, MD, specializes in clinical and surgical treatment of macular and retinal diseases, including age-related macular degeneration (AMD), and is an expert in high-resolution retinal imaging.

Dr. Schmitz-Valckenberg co-founded and directed the Grading of Digital Fundus Examination Reading Center at the University of Bonn, Germany, where he was the Department of Ophthalmology’s assistant medical director. As an expert in high-resolution retinal and fundus autofluorescence imaging, he has used various imaging techniques to map the stages of decline in AMD. Researchers worldwide use this mapping to measure outcomes during interventional clinical trials.

At Moran, Dr. Schmitz-Valckenberg is directing an ophthalmic image reading center that will play a key role in the Sharon Eccles Steele Center for Translational Medicine's drive to take a new therapy for a prevalent form of AMD into clinical trials.

Dr. Schmitz-Valckenberg holds a Jon M. Huntsman Presidential Chair at the University of Utah and is a prolific researcher with more than 165 publications and 120 peer-reviewed articles. His honors include being named by The Ophthalmologist to its Power List 2017: Top 50 Rising Stars.

Get to know Dr. Schmitz-Valckenberg by watching his profile video.

Board Certification and Academic Information

Academic Departments Ophthalmology & Visual Sciences -Professor
Board Certification
Medical Association of North Rhine-Ophthalmology
European Board of Ophthalmology

Education history

Professional Medical Medicine - Ruprecht-Karls-University Heidelberg M.D.

Selected Publications

Journal Article

  1. Pfau M, von der Emde L, Dysli C, Möller PT, Thiele S, Lindner M, Schmid M, Rubin DL, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2020). Determinants of Cone and Rod Functions in Geographic Atrophy: AI-Based Structure-Function Correlation. American journal of ophthalmology, 217, 162-173.
  2. Paul C, Heun C, Müller HH, Hoerauf H, Feltgen N, Wachtlin J, Kaymak H, Mennel S, Koss MJ, Fauser S, Maier MM, Schumann RG, Mueller S, Chang P, Schmitz-Valckenberg S, Kazerounian S, Szurman P, Lommatzsch A, Bertelmann (2018). Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study. The British journal of ophthalmology, 102(8), 1092-1097.
  3. Pfau M, Lindner M, Steinberg JS, Thiele S, Brinkmann CK, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2018). Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases. The British journal of ophthalmology, 102(8), 1054-1059.
  4. Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan (2020). Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study. The British journal of ophthalmology, 104(4), 493-499.
  5. Thiele S, Nadal J, Pfau M, Saßmannshausen M, Fleckenstein M, Holz FG, Schmid M, Schmitz-Valckenberg (2020). Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression. The British journal of ophthalmology,
  6. Liakopoulos S, Spital G, Brinkmann CK, Schick T, Ziemssen F, Voegeler J, Koch M, Kirchhof B, Holz FG, Pauleikhoff D, Schmitz-Valckenberg (2020). ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD). The British journal of ophthalmology,
  7. Brasse K, Schmitz-Valckenberg S, Jünemann A, Roider J, Hoerauf (2019). [YAG laser vitreolysis for treatment of symptomatic vitreous opacities]. Der Ophthalmologe, 116(1), 73-84.
  8. Brinkmann CK, Chang P, ,Schick T, Heimes B, Vögeler J, Haegele B, Kirchhof B, Holz FG, Pauleikhoff D, Ziemssen F, Liakopoulos S, Spital G, Schmitz-Valckenberg (2018). Initial diagnosis and indication for anti-vascular endothelial growth factor therapy in retinal diseases. Der Ophthalmologe,
  9. Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK, Luhmann UFO, Asmus F, Holz FG, MACUSTAR-Konsortium (2019). [Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR]. Der Ophthalmologe, 116(12), 1186-1193.
  10. Schmitz-Valckenberg S, Kühlewein L, Waldstein SM, Spital G, Ziemssen F, Liakopoulos (2020). Second Opinion in Retinal Imaging. Der Ophthalmologe, 117(4), 326-330.
  11. Schmitz-Valckenberg S, Brasse K, Hoerauf (2020). [Vitreous floaters]. Der Ophthalmologe, 117(5), 485-496.
  12. Pfau M, Walther G, von der Emde L, Berens P, Faes L, Fleckenstein M, Heeren TFC, Kortüm K, Künzel SH, Müller PL, Maloca PM, Waldstein SM, Wintergerst MWM, Schmitz-Valckenberg S, Finger RP, Holz F (2020). [Artificial intelligence in ophthalmology : Guidelines for physicians for the critical evaluation of studies]. Der Ophthalmologe, 117(10), 973-988.
  13. Pielen A, Feltgen N, Hattenbach LO, Hoerauf H, Bertelmann T, Quiering C, Vögeler J, Priglinger S, Lang GE, Schmitz-Valckenberg S, Wolf A, Rehak (2020). Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials. Current eye research, 45(5), 604-614.
  14. Meyer JH, Larsen PP, Strack C, Harmening WM, Krohne TU, Holz FG, Schmitz-Valckenberg (2019). Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization. Experimental eye research, 184, 162-171.
  15. Pfau M, Lindner M, Gliem M, Steinberg JS, Thiele S, Finger RP, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2018). Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen. Eye (London, England), 32(12), 1819-1830.
  16. von der Emde L, Pfau M, Holz FG, Fleckenstein M, Kortuem K, Keane PA, Rubin DL, Schmitz-Valckenberg (2021). AI-based structure-function correlation in age-related macular degeneration. Eye (London, England), 35(8), 2110-2118.
  17. Paul C, Krug P, Muller HH, Wachtlin J, Mennel S, Muller S, Schmitz-Valckenberg S, Bertelmann T, Schumann R (2018). Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth?. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 256(10), 1817-1822.
  18. Thiele S, Pfau M, Larsen PP, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2018). Multimodal Imaging Patterns for Development of Central Atrophy Secondary to Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 59(4), AMD1-AMD11.
  19. Lindner M, Kosanetzky S, Pfau M, Nadal J, Gordt LA, Schmitz-Valckenberg S, Schmid M, Holz FG, Fleckenstein (2018). Local Progression Kinetics of Geographic Atrophy in Age-Related Macular Degeneration Are Associated With Atrophy Border Morphology. Investigative ophthalmology & visual science, 59(4), AMD12-AMD18.
  20. Sassmannshausen M, Steinberg JS, Fimmers R, Pfau M, Thiele S, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2018). Structure-Function Analysis in Patients With Intermediate Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 59(3), 1599-1608.
  21. Müller PL, Pfau M, Möller PT, Nadal J, Schmid M, Lindner M, de Sisternes L, Stöhr H, Weber BHF, Neuhaus C, Herrmann P, Schmitz-Valckenberg S, Holz FG, Fleckenstein (2018). Choroidal Flow Signal in Late-Onset Stargardt Disease and Age-Related Macular Degeneration: An OCT-Angiography Study. Investigative ophthalmology & visual science, 59(4), AMD122-AMD131.
  22. Welker SG, Pfau M, Heinemann M, Schmitz-Valckenberg S, Holz FG, Finger R (2018). Retest Reliability of Mesopic and Dark-Adapted Microperimetry in Patients With Intermediate Age-Related Macular Degeneration and Age-Matched Controls. Investigative ophthalmology & visual science, 59(4), AMD152-AMD159.
  23. Pfau M, von der Emde L, Dysli C, Thiele S, Möller PT, Lindner M, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein (2019). Light Sensitivity Within Areas of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 60(12), 3992-4001.
  24. Künzel SH, Möller PT, Lindner M, Goerdt L, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau (2020). Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 61(5), 63.
  25. Sassmannshausen M, Pfau M, Thiele S, Fimmers R, Steinberg JS, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2020). Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 61(10), 19.
  26. Fleckenstein M, Thiele S, Pfau M, Schmitz-Valckenberg S, Holz F (2019). [Dry Age-Related Macular Degeneration - Epidemiology and Classification]. Klinische Monatsblatter fur Augenheilkunde, 236(9), 1068-1075.
  27. Raber FP, Reinking K, Schmitz-Valckenberg S, Althaus K, Kaut O, Witry M, Lang G (2020). [Successful Systemic Lysis Therapy in Acute Retinal Arterial Occlusions]. Klinische Monatsblatter fur Augenheilkunde, 237(6), 772-779.
  28. Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, Souied EH, Cohen SY, Querques G, Ohno-Matsui K, Boyer D, Gaudric A, Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A, Singerman L, Luthert P, Schmitz-Valckenberg S, Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ, Guymer R, Yannuzzi LA, Chew EY, Csaky K, Monés JM, Pauleikhoff D, Tadayoni R, Fujimoto (2020). Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology, 127(5), 616-636.
  29. Guymer RH, Rosenfeld PJ, Curcio CA, Holz FG, Staurenghi G, Freund KB, Schmitz-Valckenberg S, Sparrow J, Spaide RF, Tufail A, Chakravarthy U, Jaffe GJ, Csaky K, Sarraf D, Monés JM, Tadayoni R, Grunwald J, Bottoni F, Liakopoulos S, Pauleikhoff D, Pagliarini S, Chew EY, Viola F, Fleckenstein M, Blodi BA, Lim TH, Chong V, Lutty J, Bird AC, Sadda S (2020). Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. Ophthalmology, 127(3), 394-409.
  30. Holekamp N, Wykoff CC, Schmitz-Valckenberg S, Monés J, Souied EH, Lin H, Rabena MD, Cantrell RA, Henry EC, Tang F, Swaminathan B, Martin J, Ferrara D, Staurenghi (2020). Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials. Ophthalmology, 127(6), 769-783.
  31. Holz FG, Oleksy P, Ricci F, Kaiser PK, Kiefer J, Schmitz-Valckenberg S, COLUMBUS-AMD Study Group (2021). Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration. Ophthalmology, 129, 54-63.
  32. Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Margaron P, Normand G, Durbin MK, Luhmann UFO, Zamiri P, Cunha-Vaz J, Asmus F, Holz FG, on behalf of the MACUSTAR consortium (2019). MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 241(2), 61-72.
  33. von der Emde L, Thiele S, Pfau M, Nadal J, Meyer J, Möller PT, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2020). Assessment of Exudative Activity of Choroidal Neovascularization in Age-Related Macular Degeneration by OCT Angiography. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 243(2), 120-128.
  34. Müller PL, Pfau M, Schmitz-Valckenberg S, Fleckenstein M, Holz F (2021). Optical Coherence Tomography-Angiography in Geographic Atrophy. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 244(1), 42-50.
  35. Huss MB, Schmitz-Valckenberg S, Finger RP, Löffler KU, Fleckenstein M, Holz FG, Pfau (2021). The Willingness of Patients to Participate in an Eye Donation Registry for Research. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 244(3), 179-186.
  36. Fang PP, Domdei N, Herrmann P, Schmitz-Valckenberg S, Holz FG, Harmening WM, Krohne T (2019). MINIMAL OPTICAL COHERENCE TOMOGRAPHY B-SCAN DENSITY FOR RELIABLE DETECTION OF INTRARETINAL AND SUBRETINAL FLUID IN MACULAR DISEASES. Retina (Philadelphia, Pa.), 39(1), 150-156.
  37. Pfau M, Lindner M, Goerdt L, Thiele S, Nadal J, Schmid M, Schmitz-Valckenberg S, Sadda SR, Holz FG, Fleckenstein M, Fundus Autofluorescence in Age-Related Macular Degeneration Study Group (2019). PROGNOSTIC VALUE OF SHAPE-DESCRIPTIVE FACTORS FOR THE PROGRESSION OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina (Philadelphia, Pa.), 39(8), 1527-1540.
  38. Pfau M, Müller PL, von der Emde L, Lindner M, Möller PT, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2020). MESOPIC AND DARK-ADAPTED TWO-COLOR FUNDUS-CONTROLLED PERIMETRY IN GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina (Philadelphia, Pa.), 40(1), 169-180.
  39. Schmitz-Valckenberg S, Pfau M, Fleckenstein M, Staurenghi G, Sparrow JR, Bindewald-Wittich A, Spaide RF, Wolf S, Sadda SR, Holz F (2021). Fundus autofluorescence imaging. Progress in retinal and eye research, 81, 100893.
  40. Pfau M, Jolly JK, Wu Z, Denniss J, Lad EM, Guymer RH, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2021). Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials. Progress in retinal and eye research, 82, 100907.
  41. Behning C, Fleckenstein M, Pfau M, Adrion C, Goerdt L, Lindner M, Schmitz-Valckenberg S, Holz FG, Schmid (2021). Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation. BMC medical research methodology, 21(1), 170.
  42. Berger M, Schmid M, Welchowski T, Schmitz-Valckenberg S, Beyersmann (2020). Subdistribution hazard models for competing risks in discrete time. Biostatistics (Oxford, England), 21(3), 449-466.
  43. Terheyden JH, Holz FG, Schmitz-Valckenberg S, Lüning A, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Sánchez CI, Hoyng C, Margaron P, Zakaria N, Durbin M, Luhmann U, Zamiri P, Cunha-Vaz J, Martinho C, Leal S, Finger RP, MACUSTAR consortium (2020). Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR. Trials, 21(1), 659.
  44. Hattenbach LO, Feltgen N, Bertelmann T, Schmitz-Valckenberg S, Berk H, Eter N, Lang GE, Rehak M, Taylor SR, Wolf A, Weiss C, Paulus EM, Pielen A, Hoerauf (2018). Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B). Acta ophthalmologica, 96(1), e10-e18.
  45. Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A, Berk H, Eter N, Lang GE, Pielen A, Schmitz-Valckenberg S, Quiering C, Rose U, Hoerauf H, COMRADE Study Group (2018). Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. Acta ophthalmologica, 96(8), e933-e941.
  46. Gattoussi S, Buitendijk GHS, Peto T, Leung I, Schmitz-Valckenberg S, Oishi A, Wolf S, Deák G, Delcourt C, Klaver CCW, Korobelnik JF, European Eye Epidemiology (E3) consortium (2019). The European Eye Epidemiology spectral-domain optical coherence tomography classification of macular diseases for epidemiological studies. Acta ophthalmologica, 97(4), 364-371.
  47. Callizo J, Ziemssen F, Bertelmann T, Feltgen N, Vögeler J, Koch M, Eter N, Liakopoulos S, Schmitz-Valckenberg S, Spital (2019). Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study. Clinical ophthalmology (Auckland, N.Z.), 13, 2167-2179.
  48. Wachtlin J, Spital G, Schmitz-Valckenberg S, Liakopoulos S, Vögeler J, Müller B, Ziemssen F, Ocean Study Grou (2020). Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany. Journal of ophthalmology, 2020, 8024258.
  49. Ziemssen F, Wachtlin J, Kuehlewein L, Gamulescu MA, Bertelmann T, Feucht N, Voegeler J, Koch M, Liakopoulos S, Schmitz-Valckenberg S, Spital G, OCEAN study group (2018). Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes therapy, 9(6), 2271-2289.
  50. von der Emde L, Pfau M, Dysli C, Thiele S, Möller PT, Lindner M, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2019). Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration. Scientific reports, 9(1), 11132.
  51. Wintergerst MWM, Gorgi Zadeh S, Wiens V, Thiele S, Schmitz-Valckenberg S, Holz FG, Finger RP, Schultz (2020). Replication and Refinement of an Algorithm for Automated Drusen Segmentation on Optical Coherence Tomography. Scientific reports, 10(1), 7395.
  52. Barkana Y, Pondorfer SG, Schmitz-Valckenberg S, Russ H, Finger R (2021). Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration. Scientific reports, 11(1), 4764.
  53. Müller PL, Pfau M, Mauschitz MM, Möller PT, Birtel J, Chang P, Gliem M, Schmitz-Valckenberg S, Fleckenstein M, Holz FG, Herrmann (2018). Comparison of Green Versus Blue Fundus Autofluorescence in ABCA4-Related Retinopathy. Translational vision science & technology, 7(5), 13.
  54. von der Emde L, Pfau M, Thiele S, Möller PT, Hassenrik R, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2018). Mesopic and Dark-Adapted Two-Color Fundus-Controlled Perimetry in Choroidal Neovascularization Secondary to Age-Related Macular Degeneration. Translational vision science & technology, 8(1), 7.
  55. Meyer JH, Marx J, Strack C, Holz FG, Schmitz-Valckenberg (2020). Imaging of Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Inhibitors by Optical Coherence Tomography Angiography in a Rat Model. Translational vision science & technology, 9(7), 29.
  56. Pfau M, Sahu S, Rupnow RA, Romond K, Millet D, Holz FG, Schmitz-Valckenberg S, Fleckenstein M, Lim JI, de Sisternes L, Leng T, Rubin DL, Hallak J (2021). Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration. Translational vision science & technology, 10(7), 30.
  57. Grassmann F, Harsch S, Brandl C, Kiel C, Nürnberg P, Toliat MR, Fleckenstein M, Pfau M, Schmitz-Valckenberg S, Holz FG, Chew EY, Swaroop A, Ratnapriya R, Klein ML, Mulyukov Z, Zamiri P, Weber BH (2019). Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration. JAMA ophthalmology,
  58. Pfau M, von der Emde L, de Sisternes L, Hallak JA, Leng T, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Rubin D (2020). Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration. JAMA ophthalmology, 138(10), 1026-1034.
  59. Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew E (2021). Age-related macular degeneration. Nature reviews. Disease primers, 7(1), 31.
  60. Lindner M, Pfau M, Czauderna J, Goerdt L, Schmitz-Valckenberg S, Holz FG, Fleckenstein (2019). Determinants of Reading Performance in Eyes with Foveal-Sparing Geographic Atrophy. Ophthalmology. Retina, 3(3), 201-210.
  61. Thiele S, Nadal J, Pfau M, Saßmannshausen M, von der Emde L, Fleckenstein M, Holz FG, Schmid M, Schmitz-Valckenberg S, Molecular Diagnostic of Age-related Macular Degeneration Study Group (2020). Prognostic Value of Retinal Layers in Comparison with Other Risk Factors for Conversion of Intermediate Age-related Macular Degeneration. Ophthalmology. Retina, 4(1), 31-40.
  62. Pfau M, Möller PT, Künzel SH, von der Emde L, Lindner M, Thiele S, Dysli C, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein (2020). Type 1 Choroidal Neovascularization Is Associated with Reduced Localized Progression of Atrophy in Age-Related Macular Degeneration. Ophthalmology. Retina, 4(3), 238-248.
  63. Saßmannshausen M, Zhou J, Pfau M, Thiele S, Steinberg J, Fleckenstein M, Holz FG, Schmitz-Valckenberg (2021). Longitudinal Analysis of Retinal Thickness and Retinal Function in Eyes with Large Drusen Secondary to Intermediate Age-Related Macular Degeneration. Ophthalmology. Retina, 5(3), 241-250.
  64. Jaffe GJ, Chakravarthy U, Freund KB, Guymer RH, Holz FG, Liakopoulos S, Monés JM, Rosenfeld PJ, Sadda SR, Sarraf D, Schmitz-Valckenberg S, Spaide RF, Staurenghi G, Tufail A, Curcio C (2020). Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5. Ophthalmology. Retina, 5, 855-867.
  65. Wu Z, Pfau M, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Staurenghi G, Bjelopera E, Brown T, Chang P, Choong J, Corradetti G, Corvi F, Domalpally A, Hurtenbach C, Nittala MG, Olson A, Pak JW, Pappe J, Saßmannshausen M, Skalak C, Thiele S, Guymer RH, Schmitz-Valckenberg (2021). OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6. Ophthalmology. Retina, 6, 4-14.
  66. Saßmannshausen M, Thiele S, Behning C, Pfau M, Schmid M, Leal S, Luhmann UFO, Finger RP, Holz FG, Schmitz-Valckenberg S, MACUSTAR Consortium (2022). Intersession Repeatability of Structural Biomarkers in Early and Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report. Translational vision science & technology, 11(3), 27.
  67. Holz FG, Schmitz-Valckenberg S, Wolf A, Agostini H, Lorenz K, Pielen A, Feltgen N, Guthoff R, Quiering C, Clemens A, Jaeger (2022). A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration-the FALCON study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
  68. Schmitz-Valckenberg S, Fleckenstein M, Zouache MA, Pfau M, Pappas C, Hageman JL, Agrón E, Malley C, Keenan TDL, Chew EY, Hageman G (2022). Progression of Age-Related Macular Degeneration Among Individuals Homozygous for Risk Alleles on Chromosome 1 (CFH-CFHR5) or Chromosome 10 (ARMS2/HTRA1) or Both. JAMA ophthalmology, 140(3), 252-260.
  69. Rieck S, Kilgus S, Meyer JH, Huang H, Zhao L, Matthey M, Wang X, Schmitz-Valckenberg S, Fleischmann BK, Wenzel (2021). Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis. Arteriosclerosis, thrombosis, and vascular biology, 41(12), 2974-2989.
  70. Künzel SH, Lindner M, Sassen J, Möller PT, Goerdt L, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau (2021). Association of Reading Performance in Geographic Atrophy Secondary to Age-Related Macular Degeneration With Visual Function and Structural Biomarkers. JAMA ophthalmology, 139(11), 1191-1199.
  71. Pfau M, van Dijk EHC, van Rijssen TJ, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Boon CJ (2021). Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence. Scientific reports, 11(1), 20446.
  72. Schmitz-Valckenberg S, Braun MD, Thiele S, Ferrara D, Honigberg L, Gao SS, Chen H, Steffen V, Holz FG, Saßmannshausen (2021). Conversion from Intermediate Age-Related Macular Degeneration to Geographic Atrophy in a Proxima B Subcohort Using a Multimodal Approach. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 244(6), 523-534.
  73. Dhooge PPA, Möller PT, Meland N, Stingl K, Boon CJF, Lotery AJ, Parodi MB, Herrmann P, Klein W, Fsadni MG, Wheeler-Schilling TH, Holz FG, Hoyng CB, Schmitz-Valckenberg S, Soraprazan Consortiu (2023). Repeatability of Quantitative Autofluorescence Imaging in a Multicenter Study Involving Patients With Recessive Stargardt Disease 1. Translational vision science & technology, 12(2), 1.
  74. Saßmannshausen M, Behning C, Weinz J, Goerdt L, Terheyden JH, Chang P, Schmid M, Poor SH, Zakaria N, Finger RP, Holz FG, Pfau M, Schmitz-Valckenberg S, Thiele S, MACUSTAR consortium member (2022). Characteristics and Spatial Distribution of Structural Features in Age-Related Macular Degeneration: A MACUSTAR Study Report. Ophthalmology. Retina,
  75. Garzone D, Terheyden JH, Morelle O, Wintergerst MWM, Saßmannshausen M, Schmitz-Valckenberg S, Pfau M, Thiele S, Poor S, Leal S, Holz FG, Finger RP, MACUSTAR Consortiu (2022). Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report. Scientific reports, 12(1), 21911.
  76. Pfau M, Schmitz-Valckenberg S, Ribeiro R, Safaei R, McKeown A, Fleckenstein M, Holz F (2022). Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy. Scientific reports, 12(1), 17870.
  77. Faatz H, Feltgen N, Gutfleisch M, Heimes-Bussmann B, Krohne TU, Liakopoulos S, Liegl R, Lommatzsch A, Mussinghoff P, Rehak M, Schmitz-Valckenberg S, Spital G, Stanzel B, Ziemssen F, Hägele B, Junkes C, Porstner M, Vögeler J, Gmeiner B, Pauleikhoff (2022). [Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD]. Die Ophthalmologie,
  78. Saßmannshausen M, Behning C, Isselmann B, Schmid M, Finger RP, Holz FG, Schmitz-Valckenberg S, Pfau M, MACUSTAR Consortium, Thiele (2022). Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report. Scientific reports, 12(1), 14933.
  79. Bindewald-Wittich A, Dolar-Szczasny J, Kuenzel SH, von der Emde L, Pfau M, Rejdak R, Schmitz-Valckenberg S, Ach T, Dreyhaupt J, Holz F (2022). Blue-light fundus autofluorescence imaging of pigment epithelial detachments. Eye (London, England),
  80. Wu Z, Schmitz-Valckenberg S, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Bonse M, Brown T, Choong J, Clifton B, Corradetti G, Corvi F, Dieu AC, Dooling V, Pak JW, Saßmannshausen M, Skalak C, Thiele S, Guymer R (2023). Reticular Pseudodrusen: Interreader Agreement of Evaluation on OCT Imaging in Age-Related Macular Degeneration. Ophthalmology science, 3(4), 100325.
  81. Schmitz-Valckenberg S, Saßmannshausen M, Braun M, Steffen V, Gao SS, Honigberg L, Ferrara D, Pfau M, Holz F (2023). Inter-Reader Agreement and Longitudinal Progression of Incomplete/Complete Retinal Pigment Epithelium and Outer Retinal Atrophy in AMD. Ophthalmology. Retina,
  82. Weber C, Stasik I, Herrmann P, Schmitz-Valckenberg S, Holz FG, Liegl (2023). Early Vitrectomy with Silicone Oil Tamponade in the Management of Postoperative Endophthalmitis. Journal of clinical medicine, 12(15),
  83. Spaide T, Jiang J, Patil J, Anegondi N, Steffen V, Kawczynski MG, Newton EM, Rabe C, Gao SS, Lee AY, Holz FG, Sadda S, Schmitz-Valckenberg S, Ferrara (2023). Geographic Atrophy Segmentation Using Multimodal Deep Learning. Translational vision science & technology, 12(7), 10.
  84. de Vente C, Valmaggia P, Hoyng CB, Holz FG, Islam MM, Klaver CCW, Boon CJF, Schmitz-Valckenberg S, Tufail A, Saßmannshausen M, Sánchez CI, MACUSTAR Consortiu (2024). Generalizable Deep Learning for the Detection of Incomplete and Complete Retinal Pigment Epithelium and Outer Retinal Atrophy: A MACUSTAR Report. Translational vision science & technology, 13(9), 11.
  85. Künzel SH, Broadbent E, Möller PT, Lindner M, Goerdt L, Czauderna J, Schmitz-Valckenberg S, Holz FG, Pfau M, Fleckenstein (2024). Association of Lesion Location and Functional Parameters with Vision-Related Quality of Life in Geographic Atrophy Secondary to Age-related Macular Degeneration. Ophthalmology. Retina, 8(8), 794-803.
  86. Guymer R, Bailey C, Chaikitmongkol V, Chakravarthy U, Chaudhary V, Finger RP, Gallego-Pinazo R, Chuan AKH, Ishida S, Lövestam-Adrian M, Parravano M, Luna Pinto JD, Schmitz-Valckenberg S, Sheth V, Souied EH, Chi GC, Gilberg F, Glittenberg C, Scheidl S, Bengus (2023). Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice. Ophthalmology science, 4(3), 100442.
  87. Saßmannshausen M, Döngelci S, Vaisband M, von der Emde L, Sloan KR, Hasenauer J, Holz FG, Schmitz-Valckenberg S, Ach (2024). Spatially Resolved Association of Structural Biomarkers on Retinal Function in Non-Exudative Age-Related Macular Degeneration Over 4 Years. Investigative ophthalmology & visual science, 65(4), 45.
  88. Zouache MA, Richards BT, Pappas CM, Anstadt RA, Liu J, Corsetti T, Matthews S, Seager NA, Schmitz-Valckenberg S, Fleckenstein M, Hubbard WC, Thomas J, Hageman JL, Williams BL, Hageman G (2024). Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression. Nature communications, 15(1), 443.
  89. von der Emde L, Mallwitz M, Vaisband M, Hasenauer J, Saßmannshausen M, Terheyden JH, MACUSTAR Consortium, Sloan KR, Schmitz-Valckenberg S, Finger RP, Holz FG, Ach (2023). Retest variability and patient reliability indices of quantitative fundus autofluorescence in age-related macular degeneration: a MACUSTAR study report. Scientific reports, 13(1), 17417.
  90. Dhooge PPA, Möller PT, Boon CJF, Lotery AJ, Herrmann P, Battaglia Parodi M, Klein W, Fsadni MG, Wheeler-Schilling TH, Jungmann O, Müller H, Holz FG, Schmitz-Valckenberg S, Peters TM, Stingl K, Hoyng CB, Soraprazan Consortiu (2022). The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients. Open research Europe, 1, 96.
  91. Terheyden JH, Holz FG, Behning C, Dunbar HMP, Schmitz-Valckenberg S, Tufail A, Schmid M, Crabb DP, Saßmannshausen M, Binns A, Hoyng CB, Zakaria N, Poor S, Moll KP, Cosette D, Martinho C, Batuca J, Cunha-Vaz J, Luhmann UFO, Leal S, Finger RP, MACUSTAR consortiu (2025). The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 1-11.
  92. Anegondi N, Steffen V, Sadda SR, Schmitz-Valckenberg S, Tufail A, Csaky K, Lad EM, Kaiser PK, Ferrara D, Chakravarthy (2024). Visual Loss in Geographic Atrophy: Learnings from the Lampalizumab Trials. Ophthalmology,
  93. Künzel SH, Broadbent E, Möller PT, Lindner M, Goerdt L, Czauderna J, Schmitz-Valckenberg S, Holz FG, Pfau M, Fleckenstein (2023). Impact of lesion location and functional parameters on vision-related quality of life in geographic atrophy secondary to AMD.
  94. Wu Z, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Schmitz-Valckenberg S, Bonse M, Brown T, Choong J, Clifton B, Corradetti G, Hodgson LAB, Lentzsch AM, Mahmoudi A, Pak JW, Saßmannshausen M, Skalak C, von der Emde L, Winkler J, Guymer R (2025). OCT-Defined Atrophic Age-Related Macular Degeneration Changes Associated with Deep Visual Sensitivity Losses: A Multicenter Study. Ophthalmology science, 5(6), 100884.
  95. Wu Z, Sadda SR, Ach T, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Curcio CA, Ferris FL 3rd, Fleckenstein M, Freund KB, Grunwald JE, Holz FG, Jaffe GJ, Liakopoulos S, Lim TH, Monés JM, Pagliarini S, Pauleikhoff D, Pfau M, Rosenfeld PJ, Sarraf D, Schmitz-Valckenberg S, Spaide RF, Sparrow JR, Staurenghi G, Tufail A, Viola F, Guymer R (2025). Onset of End-Stage Atrophic Age-Related Macular Degeneration as an End Point-A Delphi Study: Classification of Atrophy Meetings Report 7. Ophthalmology science, 5(5), 100777.
  96. Schloesser L, Terheyden JH, Behning C, Klinkhammer H, Garzone D, Saßmannshausen M, Thiele S, Schmitz-Valckenberg S, Hoyng C, Sánchez CI, Schmid M, Luhmann UFO, Floyd H, Leal S, Holz FG, Finger RP, MACUSTAR Consortiu (2025). Associations Between Structural Phenotype and Polygenic Risk Scores in Intermediate Age-Related Macular Degeneration - A MACUSTAR Report. Translational vision science & technology, 14(9), 37.
  97. Heimes-Bussmann B, Bellenbaum R, Njoo C, Liakopoulos S, Schmitz-Valckenberg S, Zortel M, Rothaus K, Leemhuis J, Mussinghoff P, Lommatzsch (2025). [Faricimab in previously treated neovascular age-related macular degeneration : Study design of the prospective noninterventional study PASSENGER]. Die Ophthalmologie, 122(9), 693-699.
  98. Liermann YN, Behning C, Isselmann B, Schmid M, Dunbar HMP, Luhmann UFO, Finger RP, Schmitz-Valckenberg S, Holz FG, Pfau M, Luu CD, Saßmannshausen M, Thiele S, MACUSTAR consortiu (2025). Ellipsoid zone reflectivity as a functional imaging biomarker for age-related macular degeneration: a MACUSTAR study report. Scientific reports, 15(1), 20093.
  99. Sarraf D, Corvi F, Rosenfeld PJ, Ach T, Blodi B, Bottoni F, Cozzi M, Chakravarthy U, Chew EY, Csaky K, Cukras C, Curcio CA, Ferris FL 3rd, Freund KB, Grunwald J, Guymer RH, Holz FG, Jaffe GJ, Liakopoulos S, Lim TH, Monés JM, Owsley C, Pagliarini S, Pauleikhoff D, Schmitz-Valckenberg S, Spaide RF, Sparrow J, Tadayoni R, Tufail A, Viola F, Fraser S, Staurenghi G, Sadda S (2026). Standardizing Measurement of cRORA (Complete Retinal Pigment Epithelial and Outer Retinal Atrophy)- CAM Report 8. Ophthalmology. Retina,
  100. Kootstra SH, Pas JAAH, Dhooge PPA, Schmitz-Valckenberg S, Parodi MB, Herrmann P, Holz FG, Lotery AJ, Stingl K, Wheeler-Schilling TH, Boon CJF, Hoyng CB, Soraprazan Consortiu (2026). Mesopic microperimetry in Stargardt disease: Application and reliability. Acta ophthalmologica,
  101. Karaca I, Wei Y, Nelson R, Sassen SH, Daynes K, Clark F, Brown T, Messina A, Pfau M, Zhang Y, Schmitz-Valckenberg S, Fleckenstein (2025). Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration. Investigative ophthalmology & visual science, 66(15), 45.
  102. Gee EE, Guymer RH, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Schmitz-Valckenberg S, Bjelopera E, Brown T, Choong J, Clifton B, Hadoux X, He Y, Heathcote J, Jannaud M, Lentzsch AM, Mahmoudi A, Pak JW, Saßmannshausen M, Skalak C, von der Emde L, Wu (2026). Geographic Atrophy on Fundus Autofluorescence and Color Fundus Photographs: Association with Deep Visual Sensitivity Losses. Ophthalmology science, 6(4), 101096.

Review

  1. Müller PL, Wolf S, Dolz-Marco R, Tafreshi A, Schmitz-Valckenberg S, Holz FG, Bille J (2019). Ophthalmic Diagnostic Imaging: Retina.
  2. Terheyden JH, Schmitz-Valckenberg S, Crabb DP, Dunbar H, Luhmann UFO, Behning C, Schmid M, Silva R, Cunha-Vaz J, Tufail A, Weissgerber G, Leal S, Holz FG, Finger RP, on behalf of the MACUSTAR Consortium (2021). Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 244(5), 387-395.
  3. Kaiser PK, Schmitz-Valckenberg MS, Holz F (2022). ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR BIOSIMILARS IN OPHTHALMOLOGY. Retina (Philadelphia, Pa.), 42(12), 2243-2250.
  4. Chang P, von der Emde L, Pfau M, Künzel S, Fleckenstein M, Schmitz-Valckenberg S, Holz F (2024). [Use of artificial intelligence in geographic atrophy in age-related macular degeneration]. Die Ophthalmologie, 121(8), 616-622.
  5. Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy (2024). Age-Related Macular Degeneration: A Review. JAMA, 331(2), 147-157.
  6. Pfau M, Künzel SH, Pfau K, Schmitz-Valckenberg S, Fleckenstein M, Holz F (2023). Multimodal imaging and deep learning in geographic atrophy secondary to age-related macular degeneration. Acta ophthalmologica, 101(8), 881-890.
  7. Terheyden JH, Dunbar HMP, Schmitz-Valckenberg S, Behning C, Martinho C, Luhmann UFO, Saßmannshausen M, Lüning A, Miliu A, Aires ID, Basile PG, Batuca J, Schmid M, Moll KP, Zakaria N, Tufail A, Binns A, Crabb DP, Leal S, Finger RP, Holz FG, MACUSTAR consortiu (2025). Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study. Eye (London, England),
  8. Broadbent E, Künzel SH, Pfau M, Schmitz-Valckenberg S, Fleckenstein (2025). Age-related macular degeneration: natural history revisited in geographic atrophy. Eye (London, England), 39(2), 217-227.
  9. Huang A, Wu Z, Ansari G, Von Der Emde L, Pfau M, Schmitz-Valckenberg S, Fleckenstein M, Keenan TDL, Sadda SR, Guymer RH, Cheung CMG, Chakravarthy (2025). Geographic atrophy: Understanding the relationship between structure and function. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 14(3), 100207.

Conference Proceedings

  1. Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi (2018). Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology, 125(4), 537-548.

Editorial

  1. Holz FG, Schmitz-Valckenberg (2024). [Artificial intelligence (AI) in age-related macular degeneration]. Die Ophthalmologie, 121(8), 607-608.

Letter

  1. Pfau M, Schmitz-Valckenberg S, Holz FG, Fleckenstein (2022). Re: Trivizki et al. Local Geographic Atrophy Growth Rates Not Influenced by Close Proximity to Non-Exudative Type 1 Macular Neovascularization. Investigative ophthalmology & visual science, 63(5), 10.

Other

  1. Garzone D, Terheyden JH, Morelle O, Wintergerst MWM, Saßmannshausen M, Schmitz-Valckenberg S, Pfau M, Thiele S, Poor S, Leal S, Holz FG, Finger RP, MACUSTAR Consortiu (2023). Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report. Scientific reports, 13(1), 3795.